Global Stock Fund	|	International Stock Fund	|	U.S. Stock Fund

Overview	|	Characteristics	|	Risks	|	Manager Biographies

Fund Characteristics as of 31 March 2011, unless otherwise noted (updated quarterly)
General Information Net Asset Value Per Share   $11.03 €9.73 Total Net Assets (millions)   $17.3 Fund Inception Date   10 September 2010 Total Expense Ratio   0.70%(a) 2011 Portfolio Turnover   42% Minimum Investment   $100,000 £100,000 €100,000 Base Currency   U.S. Dollar Structure   UCITS Domicile   Ireland		Asset Allocation Share Classes   SEDOL ISIN USD Accumulating Class B5168Z2 IE00B5168Z23 GBP Accumulating Class   B51XV65   IE00B51XV652 EUR Accumulating Class   B55H527   IE00B55H5278
Portfolio Characteristics   Fund   MSCI EAFE Number of Stocks 84 923 Median Market Capitalization (billions)   $17   $7 Weighted Average Market Capitalization (billions)   $55   $49 Price-to-Earnings Ratio(b)   10.6x   11.4x Countries Represented   25   22 Emerging Markets (Brazil, China, India, Indonesia, Mexico, South Africa, South Korea, Thailand, Turkey, United Arab Emirates)   19.2%   0.0%		Regional Diversification (%)(d)   Fund   MSCI EAFE Europe (excluding U.K.) 44.5 42.1 United Kingdom   16.9   22.4 Japan   13.8   21.6 Africa/Middle East   7.5   0.6 Latin America   6.1   0.0 Pacific (excluding Japan)   4.8   13.3 United States   4.7   0.0
ten largest holdings (%)(c) Fund Naspers, Ltd. (South Africa)   3.8 Roche Holding AG (Switzerland)   3.3 Sanofi (France)   3.1 GlaxoSmithKline PLC (United Kingdom)   2.9 Vodafone Group PLC (United Kingdom)   2.9 Bayer AG (Germany)   2.8 Lafarge SA (France) 2.5 Novartis AG (Switzerland) 2.5 HSBC Holdings PLC (United Kingdom) 2.4 Barclays PLC (United Kingdom)   2.3		Sector Diversification (%)   Fund   MSCI EAFE Financials   21.3   22.6 Health Care   14.6   9.3 Consumer Discretionary 14.3 10.8 Information Technology   13.5   4.8 Telecommunication Services 10.1 5.5 Industrials   8.9   12.7 Materials   7.1   10.2 Energy 6.2 8.6 Consumer Staples   2.3   11.2 Utilities   0.0   4.3

(a) The Fund prospectus provides that for the fiscal periods ending 31 December 2011 and 2012, Dodge & Cox has voluntarily agreed to reimburse the Fund for all ordinary expenses to the extent necessary to maintain aggregate annual ordinary expenses at 0.70% of average daily net assets. Dodge & Cox may terminate or modify this agreement upon 30 days notice to Shareholders.
(b) Price-to-earnings (P/E) ratios are calculated using 12-month forward earnings estimates.
(c) The Fund's portfolio holdings are subject to change without notice. The mention of specific securities is not a recommendation to buy, sell, or hold any particular security and is not an indication of Dodge & Cox's current or future trading activity.
(d) The Fund may classify a company in a different category than the MSCI EAFE. The Fund generally classifies a company based on its country of incorporation, but may designate a different country in certain circumstances.

The MSCI EAFE (Europe, Australasia, Far East) Index is a broad-based, unmanaged equity market index aggregated from 22 developed market country indices, excluding the United States. MSCI makes no express or implied warranties or representations and shall have no liability whatsoever with respect to any MSCI data contained herein. The MSCI data may not be further redistributed or used as a basis for other indices or any securities or financial products. This report is not approved, reviewed, or produced by MSCI. MSCI EAFE is a service mark of MSCI Barra.

This information should not be considered a solicitation or an offer to purchase shares of Dodge & Cox Worldwide Funds plc or a solicitation or an offer by Dodge & Cox Worldwide Investments Ltd. and its affiliates to provide any services in any jurisdiction. The views expressed herein represent the opinions of Dodge & Cox Worldwide Investments Ltd. and its affiliates and are not intended as a forecast or guarantee of future results for any product or service. To obtain more information about the Funds, including risks, charges and expenses, please call +353 1 242 5411 for a prospectus.